3-Amino-3-azabicyclo[3,3,0]octane | CAS:54528-00-6

We serve 3-Amino-3-azabicyclo[3,3,0]octane CAS:54528-00-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Amino-3-azabicyclo[3,3,0]octane

CAS No: 54528-00-6
Product Name: 3-Amino-3-azabicyclo[3,3,0]octane
Other Name:
3-Amino-3-azabicyclo[3,3,0]octane
Hexahydrocyclopenta[c]pyrrol-2(1H)-amine
3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-amine
N-amino-3-azabicyclo[3.3.0]octane
 
Density: 1.0±0.1 g/cm3
Boiling Point: 188.0±9.0 °C at 760 mmHg
Molecular Formula: C7H14N2
Molecular Weight: 126.200
Flash Point: 73.2±6.7 °C
Exact Mass: 126.115700
PSA: 29.26000
LogP: 0.14
Vapour Pressure: 0.6±0.4 mmHg at 25°C
Index of Refraction: 1.528
 
Specification
Appearance: Yellow to light brown powder
Assay: 98.0~101.0%
Loss on drying: ≤0.20%
Sulphated ash: ≤0.50%
3-Nitroso-3-azabicyclo[3.3.0]octane: ≤20ppm
 
Application
Intermediates of Gliclazide CAS: 21187-98-4.
Be used as  pharmaceutical intermediate, mainly used in the synthesis of the Hypoglycemic drugs Gliclazide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Amino-3-azabicyclo[3,3,0]octane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-amino-3-azabicyclo[3.3.0]octane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-amine Use and application,Hexahydrocyclopenta[c]pyrrol-2(1H)-amine technical grade,usp/ep/jp grade.


Related News: Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves.4-Methylpyridin-2-amine manufacturer This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.D-Asparagine Monohydrate supplier This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.apocynin vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.